S&P 5007,659▼ 1.09%Nasdaq26,140▼ 2.15%Dow Jones52,002▼ 0.34%Nasdaq 10029,188▼ 2.50%VIX19.99▲ 21.45%US Dollar101.84▼ 0.21%Gold (GLD)382.01▼ 0.18%Oil (USO)161.76▲ 2.83%
Home › NOC › Research report
← NOC page
XStocksXray
Research report · 16 October 2026

Northrop Grumman Corp (NOC)

Industrials · Aerospace & Defense · US stock · price as of 16 Oct 2026

Key indicators

Price$519.86
52-week range$470.06 – $767.12
Market cap$74.0B
P/E (trailing)16.5×
EV / EBITDA14.2×
Free-cash-flow yield4.9%
Dividend yield1.8%
Revenue (last 12 months)$42.9B
Revenue growth (3y a year)4.7%
Operating margin10.7%
Return on invested capital12.8%
Net debt / EBITDA2.1×

Fair value

Blended fair value$649.94 range $625 – $677
Versus priceFair+25% to fair value
Peer multiples$654.17
Fundamentals-adjusted multiple$829.04
10-year DCF (market-scaled)$466.61
Earnings power value (floor, not blended)$223.56
Model uncertaintyMedium

X-Ray Score

50/ 100 · High confidence · ahead of 47% of sector peers
Valuation68
Growth48
Profitability29
Financial health55
Dividends57

Five-year price chart navy: price · brown: 200-day average · blue band: fair value range

294417541664788Fair value $6502021-102023-012024-042025-072026-10

Executive summary

Northrop Grumman is a defence and aerospace contractor that builds aircraft, space systems, missile defence and mission systems, and provides cyber and electronic warfare capabilities. Its main customer is the United States government, along with allied governments, and it earns money from long-term contracts for developing and producing systems and for maintaining them. Defence budgets and programme execution therefore shape its results.

Over the latest twelve months the company reported revenue of $42.9 billion, with growth of 4.7% a year across three years. It reports an operating margin of 10.7%, with return on invested capital of 13%. Leverage, measured as net debt to EBITDA, is 2.1 times. A dividend is paid, with a yield of 1.8%.

StocksXray gives Northrop Grumman Corp an X-Ray Score of 50 out of 100 (high confidence), ahead of 47% of the S&P 500 stocks in its sector. Its strongest lens is valuation (68) and its weakest is profitability (29).

Our fair value blend is $649.94 (range $624.79 to $677.20). At $519.86 the stock trades 20% below that blend, so the label is "Fair" with medium model uncertainty. Fair value is a range, not a price target.

stocksxray.com · page 1
XStocksXray
Northrop Grumman Corp (NOC)

Valuation history multiples at each fiscal year-end price; the last column uses today's price and the last twelve months

FY2021FY2022FY2023FY2024FY2025Now
Price$358.45$512.65$447.08$455.72$563.34$519.86
Market cap$57.7B$79.8B$68.0B$67.1B$81.0B$74.0B
P/E8.2×16.3×33.0×16.1×19.4×16.5×
EV / revenue1.9×2.5×2.0×1.9×2.2×2.0×
EV / EBITDA9.7×18.2×20.3×13.8×15.4×14.2×
Price / free cash flow26.8×54.4×32.4×25.6×24.5×20.3×
Free-cash-flow yield3.7%1.8%3.1%3.9%4.1%4.9%
Price / book4.5×5.2×4.6×4.4×4.9×4.1×
Dividend yield1.72%1.32%1.64%1.77%1.60%1.84%

Fundamentals checklist ● 5 Good · ● 7 Average · ● 3 Bad · each check graded against the sector

Cash quality

Earnings backed by cash−1.1%Bad
Free-cash-flow yield4.9%Average

Risk models

Altman Z score2.6×Average
Piotroski F-Score7 of 9Good

Growth

EPS growth (3y)−2.6%Bad
Free-cash-flow growth (3y)31.1%Good
Revenue growth (3y)4.7%Average
Growth consistency90%Average

Balance sheet

Current ratio1.2×Average
Net debt / EBITDA2.1×Average
Interest coverno interest costGood

Valuation

Fair value vs price1.3×Good
EBIT / EV yield5.3%Good

Profitability

Return on invested capital12.8%Average
Operating margin10.7%Bad
stocksxray.com · page 2
XStocksXray
Northrop Grumman Corp (NOC)

Financials US$ millions, from SEC filings; last column is the last twelve months

Income statementFY21FY22FY23FY24FY25LTM
Revenue35,66736,60239,29041,03341,95442,892
Gross profit––––––
Operating income5,6513,6012,5374,3704,5114,598
Net income7,0054,8962,0564,1744,1824,496
Diluted EPS ($)43.5431.4713.5328.3429.0831.43
Free cash flow2,1521,4662,1002,6213,3073,646
Gross margin––––––
Operating margin15.8%9.8%6.5%10.6%10.8%10.7%
Net margin19.6%13.4%5.2%10.2%10.0%10.5%
Balance sheetFY21FY22FY23FY24FY25LTM
Total assets42,57943,75546,54449,35951,37750,763
Cash3,5302,5773,1094,3534,4032,307
Total debt12,78312,87713,85616,27415,69615,191
Equity12,92615,31214,79515,29016,67417,884
Dividend per share ($)6.166.767.348.058.999.40

Revenue and net income US$ billions: navy revenue, teal net income

FY21FY22FY23FY24FY25

Margins blue gross, teal operating, brown net

0%7%13%20%FY21FY22FY23FY24FY25

Latest quarters

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue ($M)9,46810,35110,42311,7129,88110,876
Growth vs a year earlier−6.6%+1.3%+4.3%+9.6%+4.4%+5.1%
Net income ($M)4811,1741,1001,4278751,094
Diluted EPS ($)3.328.157.67–6.147.68
stocksxray.com · page 3
XStocksXray
Northrop Grumman Corp (NOC)

Peers in Aerospace & Defense

CompanyX-Ray
NOC · Northrop Grumman Corp50
GD · General Dynamics Corp69
TXT · Textron Inc65
LHX · L3harris Technologies, Inc...59
LMT · Lockheed Martin Corp57

Market Compass outlook for Industrials: Neutral (45/100). It blends regime history, macro sensitivity, momentum and valuation.

Returns

1 week+8.1%
1 month−0.8%
3 months−0.3%
6 months−21.2%
1 year−13.2%
3 years+15.5%
5 years+44.7%

Technical summary

DailyNeutral6 bullish · 2 neutral · 8 bearish
WeeklyStrongly bearish2 bullish · 1 neutral · 9 bearish
MonthlyBearish2 bullish · 1 neutral · 5 bearish
50-day / 200-day average$525.36 / $589.90
52-week low / high$470.06 / $767.12
Classic pivot, support and resistanceS2 497.91 · S1 508.88 · P – · R1 525.70 · R2 531.55

Recent dividends

Ex-dividend dateAmount per share
31 Aug 2026$2.4700
1 Jun 2026$2.4700
23 Feb 2026$2.3100
1 Dec 2025$2.3100
2 Sep 2025$2.3100
2 Jun 2025$2.3100
stocksxray.com · page 4
XStocksXray
Northrop Grumman Corp (NOC)

Strengths

  • Interest cover of no interest cost is ahead of 76% of its sector peers.
  • Piotroski F-Score of 7 out of 9: most of the nine accounting health tests pass.
  • Has raised its dividend for 7 years in a row.

Risks and weak spots

  • Earnings backed by cash is weak against Industrials peers (−1.1%).
  • EPS growth (3y) is weak against Industrials peers (−2.6%).
  • Operating margin is weak against Industrials peers (10.7%).

Latest SEC filings

DateFormItems
21 Aug 20268-K5.02
21 Jul 202610-Q
21 Jul 20268-K2.02,9.01
21 May 20268-K5.07
21 Apr 202610-Q
21 Apr 20268-K2.02,9.01
3 Apr 2026DEF 14A
13 Feb 20268-K5.02,9.01

How to read this report

Every number comes from SEC filings, end-of-day prices and the StocksXray models described on the methodology page. The X-Ray Score ranks each metric against the company's own sector. Fair value blends three models and carries a typical error of about 40%, so treat it as a range. Analyst ratings, price targets and earnings-call summaries are not part of this report. Educational research, not financial advice; read the disclaimer.

stocksxray.com · page 5 · generated 19 Oct 2026